# Lunit medical AI research and model development

> Developing situation record from CLSTR: https://clstr.news/situations/lunit-medical-ai-research-and-model-development
> Updated: 2026-11-06T07:41:30.000Z. Sources: 4. Developments: 2.

Medical AI company Lunit has presented research regarding its SCOPE AI biomarker platform at the SITC 2026 conference. Collaborative studies with Labcorp and CellCarta utilized AI to analyze histological features in ovarian and bladder cancers, focusing on distinguishing homologous recombination deficiency and understanding the spatial distribution of immune cells in treatment responses.

Following these research developments, Lunit announced the completion of LearningUnit 2.0, a medical-specific foundation model. Developed over ten months for the Ministry of Science and ICT, the 30 billion parameter model was released as open source. Validation studies across nine medical institutions indicated high accuracy in clinical decision support, emergency room triage, and multidisciplinary care planning.

## Timeline

### 2026-11-06: Lunit develops LearningUnit 2.0 medical AI foundation model

Lunit has released LearningUnit 2.0, an open-source medical AI foundation model designed to support clinical decision-making and administrative workflows in hospitals.

2 sources. https://clstr.news/cluster/lunit-develops-learningunit-20-medical-ai-foundation-model

### 2026-11-04: Lunit presents AI cancer biomarker research at SITC 2026

Lunit presented AI-driven research at SITC 2026, demonstrating how its Lunit SCOPE platform can analyze ovarian and bladder cancer biomarkers through spatial and histological tissue analysis.

2 sources. https://clstr.news/cluster/lunit-presents-ai-cancer-biomarker-research-at-sitc-2026

---
Cite as: Lunit medical AI research and model development. CLSTR, https://clstr.news/situations/lunit-medical-ai-research-and-model-development